Randomized clinical trial: Nucleos(t)ide analogues improved survival of CHB-related HCC patients via reducing severity and progression of malignancy

BACKGROUND: The influence of nucleos(t)ide analogues (NAs) to treat Chronic hepatitis B (CHB) related hepatocellular carcinoma (HCC) remains to be explored. AIM: To investigate if NAs reduce the severity and progression of CHB-related HCC. RESULTS: Among 532 patients, there were 118 or 414 CHB-relat...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Wang, Yun, Xiang, Xiaogang, Chen, Liwen, Cao, Zhujun, Bao, Rebecca, Zhou, Huijuan, Tang, Weiliang, Lu, Jie, Lin, Lanyi, Xie, Qing, Bao, Shisan, Wang, Hui
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2016
Sujets:
Clinical Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5295451/
https://ncbi.nlm.nih.gov/pubmed/27329718
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10155
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires